Effect of propranolol on rat brain synaptosomal Na+-K+-ATPase, Mg2+-ATPase and Ca2+-ATPase

Chemico-Biological Interactions

Volumn 103, Issue 1, 1997, Pages 51-58

  Gopalaswamy, U V ^a   Satav, J G ^a   Katyare, S S ^a   Bhattacharya, R K ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); ADENOSINE TRIPHOSPHATASE (MAGNESIUM); ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROPRANOLOL;

ANIMAL TISSUE; ARTICLE; BRAIN SYNAPTOSOME; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME KINETICS; MALE; NONHUMAN; RAT; SYNAPTIC TRANSMISSION;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BRAIN; CA(2+) MG(2+)-ATPASE; CALCIUM-TRANSPORTING ATPASES; MALE; NA(+)-K(+)-EXCHANGING ATPASE; PROPRANOLOL; RATS; RATS, WISTAR; SYNAPTOSOMES;

ANIMALIA;

EID: 0031584718     PISSN: 00092797     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0009-2797(96)03751-9     Document Type: Article

References (36)

1. [1] C.D. Jackson and L. Fishbein, A texicological review of beta adrenergic blockers, Fundam. Appl. Toxicol., 6 (1986) 395-422.
2. [2] FDA, Diuretic most prescribed, FDA Consumer, 18 (1984) 6-7.
3. [3] H.J. Sanders, New drugs for combating heart disease, Chem. Eng. News, (1982) July 12, pp. 26-38.
4. [4] K. Chadda, S. Goldstein, R. Byigton and J.D. Curb, Effect of propranolol after acute myocardial infraction in patients with congestive heart failure, Circulation, 73 (1986) 503-510.
5. [5] S. File and R.G. Lister, Comparison effects of lorazepam with propranolol on experimentally induced anxiety and performance, Br. J. Clin. Pharmacol., 19 (1985) 445-451.
6. [6] M. Pollak, J. Rosebaum and N. Cassem, Propranolol and depression revisited: three cases and a reveiw, J. Nerv. Ment. Dis., 173 (1985) 118-119.
7. [7] F. Thibaut and L. Colonna, Anti-aggressive effect of beta-blockers, Encehpale, 19 (1993) 263-267.
8. [8] S.C. Pandey, X. Ren, J. Sagen and G.N. Pandey, Beta-adrenergic receptor subtype in tress-induced behavioral depression, Farmacol. Biochem. Behav., 51 (1995) 339-344.
9. [9] F.A. Elliot, Propranolol for the control of belligerent behaviour following acute brain damage, Ann. Neurol., 1 (1977) 5.
10. [10] P. Mansheim, Treatment with propranolol of the behavioral sequelae of brain damage, Clin. Psychiatry, 42 (1981) 132-139.
11. [11] M. Y. Liu, Protective effects of propranolol on experimentally head injured mouse brain, J. Farmos. Med. Assoc., 94 (1995) 386-390.
12. [12] W.E. Harris and W.L. Stahl, Interactions of adrenergic compounds with brain membrane constituents, Biochem. Pharmacol., 27 (1978) 2015-2019.
13. 2+ -ATPase activities of synaptosomes, Biochem. Pharmacol., 30 (1981) 1799-1803.
14. [14] S. Lopez-Sanudo and E. Arilla, Modulation by isoproterenol and propranolol of somatostatin recepters in synaptosomes from rat frotopereital cortex, Brain Res., 614 (1993) 171-177.
15. [15] J.A. Street, J.G. Webb, P.S. Bright and T.E. Gaffney, Accumulation, subcellular localisation and release of propranolol from synaptosomes of rat cerebral cortex, J. Pharmacol. Exp. Ther., 229 (1984) 154-161.
16. [16] M.H. Botterblom, M.G. Freestra and E.B. Erdtsieck-Ernste, Determination of propranolol, labetalol, and clenbuterol in rat brain by high-performance liquid chromatography, J. Chromatogr. 613 (1993) 121-126.
17. [17] Y. Moriyama, H.L. Tsai and M. Futai, Energy dependent accumulation of neuron blockers causes selective inhibition of neurotransmitter uptake by brain synaptic vesicles, Arch. Biochem. Biophys. 305 (1993) 278-281.
18. [18] A.H. Tissari, P.S. Schonnofer and B.B. Bogdanski, Mechanism of biogenic amine trasport, II: relationship between sodium and the mechanism of oaubain blockade of the accumulation of serotonine and norepinephrine by synaptosomes, Mol. Pharmacol., 5 (1969) 593-604.
19. +-ATPase by norepinephrine in vivo: prevention by receptor antagonists and enhancement by repeated stimulation, Brain Res., 260 (1983) 338-341.
20. [20] M. Srivastava and N.K. Kapoor, The effect of propranolol on rat brain catecholamine biosynthesis, J. Biosci., 5 (1983) 261-266.
21. [21] R.D. Burgoyne and S.P.R. Rose, Changes in glycoprotein metabolism in the cerebral cortex following first exposure of dark-reared rats to light, J. Neurochem., 345 (1980) 510-517.
22. [22] J.M. Shallom and S.S. Katyare, Altered synaptosomal ATPase activity in rat brain following prolonged in vivo treatment with nicotine, Biochem. Pharmacol., 34 (1985) 3445-3449.
23. [23] Y. Tashima, Erythrocyte membrane proteins and adenosine triphosphatase activity, Biochem. Biophys. Res. Commun., 55 (1973) 630-635.
24. [24] C.H. Fiske and Y. Subba Row, The colorimetric determination of phosphorous, J. Biol. Chem., 66 (1925) 375-400.
25. [25] R.G. Sorensen and H.R. Mahler, Calcium-stimulated adenosine triphosphatases in synaptic membranes, J. Neurochem., 37 (1981) 1407-1418.
26. [26] O.H. Lowry, N.J. Rosebrough, A.L. Farr and R.J. Randall, protein measurement with the Folinphenol reagent, J. Biolchem., 193 (1951) 265-275.
27. [27] D.V. Godin., T.W. NG and J.M. Tucheck, Studies on the interaction of propranolol with erythrocyte membranes, Biochim. Biohpys. Acta, 436 (1976) 757-773.
28. [28] A.G. Lee, Local anaesthesia, the interaction between phospholipid and chloropromazine, propranolol and practolol, Mol. Pharmacol., 13 (1977) 474-487.
29. [29] M.A. Singer, Interaction of dibacaine and propranolol with phospholipid bilayer membranes. effects of alterations in fatty acyl composition, Biochem. Pharmacol., 26 (1977) 51-57.
30. [30] M.G. Myers, P.J. Lewis, J.L. Reid and C.T. Dollery, Brain concentration of propranolol in relation to hypotensive effect in the rabbit with obervations on brain propranolol levels in man, J. Pharmacol. Exp. Ther., 192 (1975) 327-335.
31. [31] M.A.A. Ray and P. Sen, Tissue cholinesterase inhibition by propranolol and related drugs, J. Pharm. Pharmacol., 38 (1986) 848-850.
32. [32] M. Kubo, M.F. Gardner and K.Y. Hostetler, Binding of propranolol and gentamicin to small unilamellar phospholipid vesicles: contribution of ionic acid and hydrophobic forces, Biochem. Pharmacol., 35 (1986) 3761-3765.
33. +-stimulated adanosine triphosphatase system of brain microsomes, Archs. Biochem. Biophys., 154 (1973) 56-67.
34. [34] H.I. Wangoff, A. Enz and A. Chappauis, Effect of adrenergic blockers on the activation of brain ATPase by noradrenaline, Experientia, 30 (1974) 688.
35. 2+-ATPase by propranolol, Biochem. Pharmacol., 34 (1985) 911-917.
36. +-ATPase activity in stress-exposed mice, Arzneim-Forsch, 34, (1984) 762-763.